Immuron Limited

Buy Online

Protectyn®

Protectyn® is a very special form of colostrum that is naturally boosted with antibodies and other components to protect infants from diseases of the digestive system....

Travelan®

Travelan® is an over-the-counter oral polyclonal antibody therapy that helps reduce the risk of Travellers’ Diarrhoea when you are travelling overseas....

Beating bacteria just got boosted

11 November 2023

We might like experiencing new places, but our tummies don’t always agree with us. Here’s somethi...

Immuron hails record monthly sales of Travelan

18 September 2023

Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the comp...

Immuron Ltd Newsletter (September 2023)

1 September 2023

Immuron Ltd newsletter September 2023. Updates on milesone achievements, sales, FY24 milestones and...

Q&A with Steven Lydeamore, CEO of Immuron Limited

23 August 2023

Immuron Limited is commercializing and developing a novel class of specifically targeted polyclonal ...

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of specifically targeted polyclonal antibodies.

The company presently has three drug candidates in clinical development and several in early stage preclinical development. Immuron believes its therapeutic drug candidates have the potential to transform the existing treatment paradigms for moderate to severe Campylobacteriosis, recurrent Clostridiodes difficile (C.difficle) infections, Enterotoxigenic Escherichia coli (ETEC) infections, Shigellosis (Bacillary dysentery) and travelers’ diarrhea.

Payment Options

Contact Information

Address: Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131 Australia
Phone: +613 8892 4854
Fax: +613 9899 8533

Travelan®

Protectyn®

Travelan® featured on Not Old Better Show

Buy Online

Protectyn®

Travelan®

Clinical Insights & Updates

Travelan® US Army Research and Clinical Studies unpacked

Engineered Bovine Colostrum for Clostridium Difficile Infection

Red Chip Analyst Upgrades Immuron on C-Difficile Trial Result

Recent Articles

Beating bacteria just got boosted

Immuron hails record monthly sales of Travelan

Immuron Ltd Newsletter (September 2023)

Q&A with Steven Lydeamore, CEO of Immuron Limited

Partners

Secure Shopping

Get Connected

About Us

Information

Payment Options

Contact Information